Improvement in mucosal discoid lupus erythematosus with anifrolumab

Clin Exp Dermatol. 2023 Sep 19;48(10):1165-1167. doi: 10.1093/ced/llad190.

Affiliations

¹ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
² Division of Dermatology, University of Vermont Medical Center, Burlington, VT, USA.
³ Department of Dermatology, University of Nebraska Medical Center, Omaha, NE, USA.

PMID: 37243535
DOI: 10.1093/ced/llad190

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Lupus Erythematosus, Discoid* / drug therapy
Lupus Erythematosus, Systemic*

Substances

anifrolumab
Antibodies, Monoclonal, Humanized